Goodtracet Tablets

Adult dose

Children over 12 years and adults: The dosage should be adjusted according to the intensity of pain and treatment response. The recommended starting dose is 2 tablets, and subsequently, dosing intervals should be at least 6 hours apart, but not exceeding 8 tablets a day. The minimum effective dose should be administered for as short a duration as possible. Avoid prolonged use of this medication beyond what is necessary, and if prolonged use is required due to the nature and severity of the illness, regular monitoring should be conducted to assess the need for continued administration of this medication. Elderly: Administer the usual adult dosage. However, in elderly patients over 75 years old, tramadol's elimination half-life has been shown to increase by 17%, so dosing should be at least 6 hours apart. Renal impairment: Patients with moderate renal impairment (creatinine clearance 10-30 mL/min) should have extended dosing intervals of 12 hours. Severe renal impairment (creatinine clearance less than 10 mL/min) is not recommended for this medication. Tramadol is very slowly removed during hemodialysis and filtration, thus there’s no need for re-administration for pain relief after dialysis. Liver impairment: For patients with moderate liver dysfunction, extended dosing intervals should be carefully considered. Severe liver dysfunction is contraindicated for this medication.

Child dose

Children over 12 years and adults: The dosage should be adjusted according to the intensity of pain and treatment response. The recommended starting dose is 2 tablets, and subsequently, dosing intervals should be at least 6 hours apart, but not exceeding 8 tablets a day.

This medication can cause liver damage if taken by persons who regularly consume more than three drinks per day, therefore consultation with a doctor or pharmacist is essential. This medication may rarely cause serious skin reactions; discontinue use immediately if a skin rash or hypersensitivity occurs. Tramadol, one of the ingredients in this medication, may increase the risk of seizures if the recommended dosage is exceeded and the risk is further heightened if taken with certain antidepressants or narcotics. There may also be a rare occurrence of fatal allergic reactions such as anaphylaxis, so caution is necessary. Administration of this medication to patients with acute or severe bronchial asthma may lead to life-threatening respiratory depression, therefore it should be administered in a setting with proper medical equipment. This medication can cause severe sedation or respiratory depression when taken with central nervous system depressants such as alcohol or benzodiazepines, so caution is advised with concomitant use. Patients with head injuries or increased intracranial pressure might experience worsened symptoms when taking this medication, so caution is needed. This medication contains a morphine-like ingredient that may cause psychological and physical dependence. Patients with impaired liver function should consult a physician before taking this medication and should avoid concomitant use with other drugs that may cause liver damage. Particularly, ultrarapid metabolizers of CYP2D6 may have elevated levels of the active component of this medication, leading to a significant risk of respiratory depression, so caution is required. This medication should not be administered to children under 12 years of age and adolescents under 18 years of age following certain surgeries. Patients with symptoms of sleep apnea or hypoxia should have their condition monitored continuously during treatment with this medication, and dosage adjustments or discontinuation should be considered if necessary. Elderly patients or those at risk of hyponatremia should be carefully monitored for the occurrence of hyponatremia during treatment with this medication. This medication should not be administered to patients with allergies to certain components or those experiencing severe respiratory depression, head injuries, or taking MAO inhibitors. It is also prohibited for use in patients with severe liver, kidney, or heart dysfunction, nursing mothers, or certain asthma patients. Abrupt discontinuation of this medication may lead to withdrawal symptoms, so dosage reduction should be performed gradually as per a doctor's instruction. This medication may cause drowsiness and dizziness, so caution is needed when driving or operating machinery. In the case of overdose, severe respiratory depression, seizures, liver damage, etc. may occur, so the prescribed dosage must be strictly followed and immediate contact with emergency medical services is required in an urgent situation.

Serious side effects

Hives, severe swelling (edema), anaphylactic reaction, severe allergic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe skin reactions, severe rash, blisters, skin peeling, oral/ocular mucosal pain, severe edema or urinary abnormalities, elevated blood pressure, serious neurological symptoms (seizures, confusion, vision abnormalities, paralysis, etc.), severe respiratory issues (difficulty breathing, respiratory distress, asthma attacks)

Mild side effects

• Decreased appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius. Proper storage will help preserve the medication's effectiveness and safety over time.

Appearance

Pale yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle